콘텐츠로 건너뛰기

SOLUTIONS
R&D
ABOUT US
- Overview
- History
- Partnership
- CI & BI
NEWS
CAREER

Menu

SOLUTIONS
R&D
ABOUT US
- Overview
- History
- Partnership
- CI & BI
NEWS
CAREER

pharmcadd

PharmCADD built an mRNA specialized research team.

<View Original Article>

PharmCADD built an mRNA specialized research team. 더 읽기"

PharmCADD strategically collaborated with CNRS

<View Original Article>

PharmCADD strategically collaborated with CNRS 더 읽기"

The mayor, Hyung-Jun Park of Busan proposed vitalization of local human resource and knowledge leveraged by the collaboration among local governance, academy and industry

<View Original Article>

The mayor, Hyung-Jun Park of Busan proposed vitalization of local human resource and knowledge leveraged by the collaboration among local governance, academy and industry 더 읽기"

PharmCADD signed a collaborative research contract for innovative new drug development with NeuroVenti for Autism.

<View Original Article>

PharmCADD signed a collaborative research contract for innovative new drug development with NeuroVenti for Autism. 더 읽기"

PharmCADD moved into Cambridge Innovation Center (CIC) in Boston, USA.

<View Original Article>

PharmCADD moved into Cambridge Innovation Center (CIC) in Boston, USA. 더 읽기"

PharmCADD introduced AI drug development progress to the ‘BIO KOREA 2021’

<View Original Article>

PharmCADD introduced AI drug development progress to the ‘BIO KOREA 2021’ 더 읽기"

Prime Minister Kim Boo-kyum visited the booth of PharmCADD in BIO KOREA 2021

<View Original Article>

Prime Minister Kim Boo-kyum visited the booth of PharmCADD in BIO KOREA 2021 더 읽기"

[ISSUE COMPANY] PharmCADD has developed an AI-based new drug discovery platform ‘Pharmulator’ that improves accuracy with quantum calculation.

[ISSUE COMPANY] PharmCADD has developed an AI-based new drug discovery platform ‘Pharmulator’ that improves accuracy with quantum calculation. 더 읽기"

PharmCADD CTO, Dr. Sangwook Wu won the Ministry of Science and ICT awards.

<View Original Article>

PharmCADD CTO, Dr. Sangwook Wu won the Ministry of Science and ICT awards. 더 읽기"

South Korea’s Pharmcadd bags $16M in series B financing, plans 2022 IPO.

<View Original Article>

South Korea’s Pharmcadd bags $16M in series B financing, plans 2022 IPO. 더 읽기"

← 이전 1 … 10 11 12 … 17 다음 →

Headquarters

Address : 224, Engineering Building 7, Sinseon-Ro 365, Namgu, Busan 48548, Republic of Korea
Call : 82-51-747-5681 | Fax : 82-51-747-5682

Seoul Office

Address : 1735, 280, Gwangpyeong-ro, Gangnam-gu, Seoul, Republic of Korea
Call : 82-2-564-5688 | Fax : 82-2-564-5685

E-Mail : [email protected]
Call : 82-51-747-5681

Linkedin-in Youtube

© 2021 PharmCADD. All Rights Reserved.